How prevalent is aspirin induced asthma?

Thorax

Volumn 57, Issue 7, 2002, Pages 565-566

  Knox, Alan J ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LEUKOTRIENE; PROSTAGLANDIN;

ASTHMA; DRUG INDUCED DISEASE; HUMAN; NOSE POLYP; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; PROVOCATION TEST; RHINITIS; SHORT SURVEY; WILLOW;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; ASTHMA; HUMANS; LEUKOTRIENES; PROSTAGLANDINS;

EID: 0036315197     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.57.7.565     Document Type: Short Survey

References (21)

1. Aspirin and other anti-inflammatory drugs
2. Clinical features and diagnosis of aspirin induced asthma
3. The aspirin disease
4. United airways disease: Therapeutic aspects
5. Role of leukotrienes in bronchial hyperresponsiveness and cellular responses in airways
6. Genetics of aspirin induced asthma
7. 4 synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast
8. The COX-1/COX-2 balance in asthma
9. Prevalence of asthma, aspirin intolerance, nasal polyposis and chronic obstructive pulmonary disease in a population-based study
10. Aspirin intolerance in asthma. Detection by oral challenge
11. Aspirin and concomitant idiosyncrasies in adult asthmatic patients
12. Aspirin and subtypes of asthma: Risk factor analysis
13. The prevalence of aspirin-intolerant asthma (AIA) in Australian asthmatic patients
14. Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma
15. Natural history of aspirin induced asthma
16. COX-2 expression in asthmatic airways: The story so far
17. Cyclooxygenase-2 expression during allergic inflammation in guinea-pig lungs
18. Changes in airway resistance by simultaneous exposure to TNFα and IL-1β in perfused rat lungs
19. The importance of COX-2 inhibition for aspirin induced asthma
20. Tolerability of meloxicam in patients with histories of adverse reactions to non-steroidal anti-inflammatory drugs
21. Safely of a specific COX-2 inhibitor in aspirin-induced asthma